-
2023-505046-26-00
5
2026-05-07
Colon carcinoma
-
2023-508798-94-00
5
2025-02-11
Heart failure
-
2023-504755-26-00
4
2024-10-21
Bronchiectasis
-
2023-508260-30-01
5
2024-07-30
Patients with poor prognostic OVARian cancers based on the tumor prima
-
2023-505510-26-00
5
2024-06-19
Patients in ICU with invasive mechanical ventilation and HSV throat re
-
2023-505214-23-00
5
2024-06-07
colon carcinoma
-
2023-506721-11-00
5
2024-06-04
Familial Mediterranean Fever (FMF)
-
2022-501554-11-00
4
2024-03-21
Patients with previously untreated Richter’s syndrome (RS), defined as
-
2023-505141-48-00
5
2024-03-07
Fibrosis
-
2022-501710-62-02
6
2023-06-07
Peripheral T-cell lymphoma (PTCL)
-
2023-504931-42-00
4
2021-04-06
Chronic lymphocytic leukemia/Small lymphocytic lymphoma; Richters tran
-
2022-501372-25-00
4
2024-01-10
Patients aged 18 years and older with relapsed or refractory FLT3 muta
-
2022-502103-30-00
4
2023-04-25
advanced non-squamous non-small cell lung cancer
-
2023-503640-14-00
5
2022-02-17
Newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphobla
-
2022-500237-92-00
5
2021-04-23
Newly-diagnosed high-intermediate and high-risk diffuse large B-cell l
-
2022-502478-18-00
4
2019-12-20
Acute Myeloid Leukemia (AML)
-
2022-502832-37-00
5
2019-03-01
Acute myeloid leukemia
-
2024-510704-37-00
5
2017-03-22
ER+/HER2- metastatic breast cancer
-
2022-501418-69-00
5
2023-11-21
Acute Coronary Syndrome
-
2022-502372-22-01
4
2023-10-19
Metastatic Breast Cancer HR+, HER2-
-
2022-500350-42-01
10
2022-11-07
Prevention of RSV
-
2022-500752-39-00
5
2021-11-25
Prevention of Respiratory syncytial virus (RSV) infection in infants a
-
2023-503673-38-00
5
2019-05-24
Adults at high risk of cardiovascular events without prior MI or strok
-
2023-510361-97-00
5
Newly Diagnosed RARA-positive Adult Patients with Higher-risk
Myelodys